SCOPUS 정보 검색 플랫폼

Volumn 82, Issue 2, 2001, Pages 323-328

Liposomal doxorubicin in ovarian, peritoneal, and tubal carcinoma: A retrospective comparative study of single-agent dosages

(5) Rose, Peter G a Hawthorne Maxson, Jan a Fusco, Nancy a Mossbruger, Kim a Rodriguez, Michael a

a UNIVERSITY HOSPITALS OF CLEVELAND (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; LIPOSOME; PACLITAXEL; PLATINUM;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER RESISTANCE; CANCER SURVIVAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG TOLERANCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PERITONEUM CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; UTERINE TUBE CARCINOMA;

EID: 0034903028 PISSN: 00908258 EISSN: None Source Type: Journal
DOI: 10.1006/gyno.2001.6272 Document Type: Article

Times cited : (95)

References (12)

1
- 0031055830
- Phase II study of liposomal doxorubicin in refractory ovarian cancer: Antitumor activity and toxicity modification by liposomal encapsulation
- (1997) J Clin Oncol , vol.15 , pp. 987-993
- Muggia, F.M.¹ Hainsworth, J.D.² Jeffers, S.³ Miller, P.⁴ Groshen, S.⁵ Tan, M.⁶ Roman, L.⁷ Uziely, B.⁸ Muderspach, L.⁹ Garcia, A.¹⁰ Burnett, A.¹¹ Greco, F.A.¹² Morrow, C.P.¹³ Paradiso, L.J.¹⁴ Liang, L.J.¹⁵

2
- 0033850066
- Phase II study of stealth liposomal doxorubicin (Doxil) in platinum and paclitaxel refractory epithelial ovarian cancer
- (2000) J Clin Oncol , vol.18 , pp. 3093-3100
- Gordon, A.N.¹ Granai, C.O.² Rose, P.³ Hainsworth, J.⁴ Lopez, A.⁵ Weissman, C.⁶ Rosales, R.⁷ Sharpington, T.⁸

3
- 0000388173
- Interim analysis of a phase III randomized trial of Doxil/Caelyx (D) versus topotecan (T) in the treatment of patients with relapsed ovarian cancer
- (2000) Proc Am Soc Clin Oncol , vol.19
- Gordon, A.N.¹ Fleagle, J.T.² Guthrie, D.³ Parkin, D.E.⁴ Gore, M.⁵ Lacave, A.J.⁶ Mutch, D.⁷

4
- 0033813383
- 2) in platinum/paclitaxel-refractory ovarian and fallopian tube cancers and primary carcinoma of the peritoneum
- (2000) Gynecol Oncol , vol.78 , pp. 369-372
- Markman, M.¹ Kennedy, A.² Webster, K.³ Peterson, G.⁴ Kulp, B.⁵ Belinson, J.⁶

5
- 0003200056
- A retrospective analysis of the clinical utility of liposomal doxorubicin in recurrent ovarian cancer (ROC)
- (1999) Proc Am Soc Clin Oncol , vol.18
- Campos, S.M.¹ Penson, R.T.² MacNeill, K.M.³ Berkowitz, R.S.⁴ Cook, S.E.⁵ Fuller, A.F.⁶ Goodman, A.K.⁷ Nikrui, N.⁸ Shulman, L.N.⁹ Matulonis, U.A.¹⁰ Seiden, M.V.¹¹

6
- 0030698757
- Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: A multivariate analysis of 704 patients
- (1997) Ann Oncol , vol.8 , pp. 963-968
- Eisenhauer, E.A.¹ Vermorken, J.B.² Vanglabbeke, M.³

7
- 0035165412
- Treatment of patients with ovarian cancer with pegylated liposomal doxorubicin: Analysis of toxicities and predictors of outcome
- (2001) Cancer , vol.91 , pp. 90-100
- Safra, T.¹ Groshen, S.² Jeffers, S.³ Tsao-Wei, D.D.⁴ Zhou, L.⁵ Muderspach, L.⁶ Roman, L.⁷ Morrow, C.P.⁸ Burnett, A.⁹ Muggia, F.M.¹⁰

8
- 0029961618
- Defining response of ovarian carcinoma to initial chemotherapy according to serum CA-125
- (1996) J Clin Oncol , vol.14 , pp. 1545-1551
- Rustin, G.J.¹ Nelstrop, A.E.² McClean, P.³ Brady, M.F.⁴ McGuire, W.P.⁵ Hoskins, J.⁶ Mitchell, H.⁷ Lambert, H.E.⁸

9
- 0000121237
- Randomized phase III study of cisplatin (CIS) paclitaxel (PAC) versus carboplatin (CARBO)/PAC in optimal stage III epithelial ovarian cancer (OC): A Gynecologic Oncology Group trial
- abstract
- (1999) Proc Am Soc Clin Oncol , vol.18
- Ozols, R.F.¹ Bundy, B.N.² Fowler, J.³ Clarke-Pearson, D.⁴

10
- 0000012867
- Cisplatin/paclitaxel vs carboplatin/paclitaxel in ovarian cancer: Update of an Arbeitsgemeinschaft Gynakologische Okologie (AGO) study group trial
- abstract
- (1999) Proc Am Soc Clin Oncol , vol.18
- DuBois, A.¹ Lueck, H.J.² Meier, W.³ Moebus, V.⁴ Costa, S.D.⁵ Bauknecht, T.⁶ Richter, B.⁷ Warm, M.⁸ Schroeder, W.⁹ Olbricht, S.¹⁰ Nitz, U.¹¹ Jackisch, C.¹²

11
- 0034049605
- Second-line treatment of ovarian cancer
- (2000) Oncologist , vol.5 , pp. 26-35
- Markman, M.¹ Bookman, M.A.²

12
- 0033451255
- Stabilization of disease as a useful predictor of survival following second-line chemotherapy in small cell lung cancer and ovarian cancer patients
- (1999) Int J Oncol , vol.15 , pp. 1233-1238
- Cesano, A.¹ Lane, S.R.² Poulin, R.³ Ross, G.⁴ Fields, S.Z.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.